FOR IMMEDIATE RELEASE
—Long-Time MHRA Official to Offer Insight, Guidance—
TAMPA, FLORIDA USA, 25 March 2011 - ISPE, a global not-for-profit association of 22,000 pharmaceutical science and manufacturing professionals, today announced that Bryan Wright will join ISPE as European Regulatory Affairs Advisor, effective 1 April 2011. In his new capacity, Mr. Wright will act as liaison between ISPE and European regulatory authorities to help expand relationships between regulatory bodies and ISPE, shape ISPE educational offerings, and keep ISPE Members informed of relevant regulatory developments originating from European regulatory authorities.
“We are extremely fortunate to add Bryan Wright to ISPE’s strong regulatory team,” said Bob Best, ISPE President and CEO. “Bryan’s 22 years of regulatory experience will be invaluable to ISPE as we continue our mission to help our Members facilitate global GMP solutions that will bring the pharmaceutical industry into the future.”
Mr. Wright comes to ISPE after taking early retirement from the MHRA. He joined the MHRA as an Inspector in 1989 and for the last five years has been Group Manager for the GMP & GDP Inspectorate. As a senior manager within the MHRA, Mr. Wright had oversight of the significant growth in Inspectors in that Agency in recent years in response to regulatory demand.
Mr. Wright has previous experience in community and hospital pharmacy and holds a degree in pharmacy and a Masters in pharmaceutical sciences. Over the course of his 22 years with the MHRA, Mr. Wright has managed most areas of the Inspectorate at various times, and his regulatory career encompasses GMP, GDP, GCP, GPvP, and the GLP monitoring authority.
About his early retirement from MHRA and subsequent role with ISPE, Mr. Wright said: “I am looking forward to new challenges, including utilizing the skills and knowledge I have gained from my years in the regulatory field in my new role with ISPE.”
Mr. Wright assumes the duties of the European Regulatory Affairs Advisor position from John Berridge, who will now turn his full attention to his role as Project Manager for the Society’s PQLI® Initiative, as well as other strategic projects for ISPE. Mr. Wright joins Bob Tribe, Asia-Pacific Regulatory Affairs Advisor, on ISPE’s Regulatory Affairs team.
ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 24,000 technical professionals working in or serving the manufacturing sector or drug development in the pharmaceutical industry in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop their technical knowledge, exchange practical experience within their community, enhance their professional skills, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.
Meet 2016 – 2017 ISPE International Board of Directors
Wednesday, 24 Aug 2016 19.08
Biotechnology Manufacturing – Transforming Healthcare for Millions
Tuesday, 23 Aug 2016 13.08
Future of Pharma Product Development & Production Systems
Monday, 22 Aug 2016 13.08